DNA Fragmentation Technique Market

Global DNA Fragmentation Technique Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing geriatric population, rising infertility ratio and growing adoption of advanced technologies are some of the major factors anticipated to drive the growth of the Global DNA Fragmentation Technique Market.

Global DNA Fragmentation Technique Market is valued at USD 5.45 Billion in 2021 and expected to reach USD 10.95 Billion by 2028 with the CAGR of 11.87% over the forecast period

Scope–

Artificial breaking of DNA order to use it as genomics applications is termed as DNA fragmentation. In 1970 first DNA fragmentation was reported by Williamson. The techniques of DNA fragmentation are divided into three categories which are; enzymatic methods, physical methods and chemical methods. The main objective of DNA fragmentation is to screen mutations in DNA. The applications of DNA fragmentation are for DNA sequencing, for performing DNA microarray, forensics and for detection of male infertility by studying the amount of fragmented DNA from a sperm cell.

The Covid-19 pandemic has shown significant impact on the global DNA fragmentation techniques market. The aggressive nature of Covid-19 virus caused stress in people and medical sector. The PCR based amplification method is one of the most trusted DNA fragmentation methods which was increased during pandemic for detection of Covid-19 virus. As well as, as per article published by Andrology in 2021 raised possibility that Covid‐19 virions might interact with human spermatozoa and disrupt male fertility which also possibly boost the market of DNA fragmentation post pandemic.

The global DNA fragmentation technique market is segmented based on treatment type, end users, test type and region and country level. On the basis of treatment type, the global DNA fragmentation technique market is classified into assisted reproductive technology and varicocele surgery, and medication. On the basis of test type, the market is classified into SCSA (Sperm chromatin structure assay), TUNEL assay, halo test, comet assay, and unexplained infertility treatment. On the basis of the end-user, the global DNA fragmentation technique market is classified into hospitals and clinics, fertility centers, research institutes, and others.

The regions covered in global DNA fragmentation technique market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global DNA fragmentation technique market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

Key Players-

• Merck KGaA
• Halotech DNA SL
• SCSA Diagnostics
• Vitrolife
• Cadila Healthcare Ltd
• CooperSurgical Inc
• Cryolab Ltd.
• Microm Ltd.
• Thermo Fisher Scientific
• COVARIS INC
• others

Segmentation-

By Treatment Type:

• Assisted Reproductive Technology
• Varicocele Surgery
• Medication

By Test Type:

• SCSA (Sperm chromatin structure assay)
• TUNEL Assay
• Halo Test
• Comet Assay
• Unexplained Infertility Treatment

By End Users:

• Hospitals and Clinics
• Fertility Centers
• Research Institutes
• Others

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

 

Increasing Geriatric Population, Rising Infertility Ratio and Growing Adoption of Advanced Technologies are Some of the Major Factors Driving the Market Growth

One of the major factors driving the growth of the global DNA fragmentation technique is increasing geriatric populations. As geriatric population is more prone to diseases which also supplement the demand for  DNA fragmentation techniques for disease detection. For instance; as per World Health Organization; the geriatric population will increase from one billion in 2020 to 1.4 billion and by 2050, the world’s population of people aged 60 years and older will double (2.1 billion). In addition, rising infertility ratio also boosting the market growth. The DNA fragmentation techniques are used for detection of infertility and as the number of people having infertility will directly increase the market of the global DNA fragmentation technique. For instance; as per National Institute of Health (NIH), 8% to 10% of couples globally are affected by infertility.

Moreover, growing adoption of advanced technologies also augumenting the market growth. The adoption of advanced technologies due to rapid development and modernization is driving the growth of the global DNA fragmentation techniques for the forecast period.  However, high cost of DNA fragmentation techniques may hamper the market growth. In spite of that, rising awareness about DNA fragmentation technology may offer more opportunities for the further growth of the market.

The North America is Expected to Dominate Global DNA Fragmentation Technique Market

The North America is expected to dominate the global DNA fragmentation technique market due to the rising awareness, presence of well-equipped fertility clinics and highly developed healthcare infrastructure in this region. The growing awareness about technologies and advancements in DNA fragmentation is driving the market growth in North America. In addition, presence of well-equipped fertility clinics is augmenting the market growth. For instance; as per U.S. Fertility Clinics & Infertility Service there are about 480 fertility clinics in United States. Moreover, highly developed infrastructure in North America is also augmenting the growth of DNA fragmentation techniques for the forecast period.  

 

News-

New Liquid Biopsy Method Infers RNA Expression from DNA Fragmentation Analysis

On April 8^th, 2022; A new method developed by Researchers at Stanford University of noticing cancer from circulating tumor DNA (cfDNA) that combines DNA fragmentation analysis with deep sequencing to infer RNA expression profiles of tumor cells. Diagnosis, prognosis. The method was first time used to predict RNA expression from ctDNA is a first for blood-based cancer detection. Researchers planned to expand the method to other cancers like breast and colon and test whether it can detect cancer.

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2027
Market Size in 2021:	USD 5.45 Billion
Base year considered	2020
Forecast Period CAGR %:	11.87%
Market Size Expected in 2028:	USD 10.95 Billion
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	Merck KGaA, Halotech DNA SL, SCSA Diagnostics, Vitrolife, Cadila Healthcare Ltd, CooperSurgical, Inc, Cryolab Ltd., Microm Ltd., Thermo Fisher Scientific, COVARIS, INC and others.
Segments Covered	By Treatment Type, By Test Type, By End Users
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa